{"DataElement":{"publicId":"6421694","version":"1","preferredName":"Upper Gastrointestinal Tract Neoplasm Histologic Grade Code","preferredDefinition":"A coded response used to determine the degree of abnormality of cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type of malignant tissue growth located in the upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum.","longName":"6421685v1.0:6421677v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"6421685","version":"1","preferredName":"Upper Gastrointestinal Tract Neoplasm Histologic Grade","preferredDefinition":"The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","longName":"6421727v1.0:6421691v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"6421727","version":"1","preferredName":"Upper Gastrointestinal Tract","preferredDefinition":"The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum.","longName":"C33837","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Gastrointestinal Tract","conceptCode":"C33837","definition":"The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"748326BF-928D-0A1E-E053-F662850AE7FE","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6421691","version":"1","preferredName":"Neoplasm Histologic Grade","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","longName":"C3262:C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480AD77-6D18-2B5F-E053-F662850AE28E","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480F5F2-B82D-0F19-E053-F662850A1122","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"GARRIDOJ","dateModified":"2018-11-08","changeDescription":"Created for EA2174, 08/28/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6421677","version":"1","preferredName":"Upper GI Histologic Grade Code","preferredDefinition":"A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6421677v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"3","valueDescription":"Poorly Differentiated Grade 3","ValueMeaning":{"publicId":"6421680","version":"1","preferredName":"Poorly Differentiated Grade 3","longName":"6421680","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A morphologic qualifier indicating that a cancerous lesion is poorly differentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade 3","conceptCode":"C28079","definition":"A morphologic qualifier indicating that a cancerous lesion is poorly differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480F5F2-B7C6-0F19-E053-F662850A1122","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7480F5F2-B7E1-0F19-E053-F662850A1122","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","deletedIndicator":"No"},{"value":"1","valueDescription":"Well Differentiated Grade 1","ValueMeaning":{"publicId":"6421678","version":"1","preferredName":"Well Differentiated Grade 1","longName":"6421678","preferredDefinition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.: A morphologic qualifier indicating that a cancerous lesion is well differentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade 1","conceptCode":"C28077","definition":"A morphologic qualifier indicating that a cancerous lesion is well differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480F5F2-B776-0F19-E053-F662850A1122","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7480F5F2-B791-0F19-E053-F662850A1122","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","deletedIndicator":"No"},{"value":"2","valueDescription":"Moderately Differentiated Grade 2","ValueMeaning":{"publicId":"6421679","version":"1","preferredName":"Moderately Differentiated Grade 2","longName":"6421679","preferredDefinition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.: A morphologic qualifier indicating that a cancerous lesion is moderately differentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderately Differentiated","conceptCode":"C14162","definition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade 2","conceptCode":"C28078","definition":"A morphologic qualifier indicating that a cancerous lesion is moderately differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480F5F2-B79E-0F19-E053-F662850A1122","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7480F5F2-B7B9-0F19-E053-F662850A1122","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","deletedIndicator":"No"},{"value":"4","valueDescription":"Cannot Be Assessed Grade X","ValueMeaning":{"publicId":"6421681","version":"1","preferredName":"Cannot Be Assessed Grade X","longName":"6421681","preferredDefinition":"Aspects of the context prevent the evaluation needed to determine a value.: A morphologic qualifier indicating that the grade of a neoplasm cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cannot Be Assessed","conceptCode":"C48657","definition":"Aspects of the context prevent the evaluation needed to determine a value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade X","conceptCode":"C113730","definition":"A morphologic qualifier indicating that the grade of a neoplasm cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480F5F2-B7EE-0F19-E053-F662850A1122","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7480F5F2-B809-0F19-E053-F662850A1122","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","deletedIndicator":"No"},{"value":"99","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7480F5F2-B81D-0F19-E053-F662850A1122","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480F5F2-B75A-0F19-E053-F662850A1122","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"GARRIDOJ","dateModified":"2018-11-08","changeDescription":"Created for EA2174, 08/28/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"6059865","version":"1","longName":"Diagnostic Procedure","context":"ECOG-ACRIN"},{"publicId":"10000047","version":"1","longName":"Pathology","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic grade","type":"Preferred Question Text","description":"Histologic grade","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480E137-A5DD-0EA8-E053-F662850A2C87","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeDescription":"Created for EA2174, 08/28/2018","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}